Transgenic mice expressing the c-myc proto-oncogene under the control of the Ig heavy chain enhancer (€p-myc) all eventually develop clonal pre-B-or B-cell tumors. The preneoplastic period is characterized by increased polyclonal proliferation of pro-B and pre-B cells in the bone marrow (BM) associated with a reduced number of B cells, suggesting a high degree of B-cell loss. To examine the mechanisms of this cell loss, we have identified B220' B-lineage cells within the BM of pretumorous €p-myc transgenic mice by in vivo radiolabeling and electron microscope radioautography. Large mitotic B220+-labeled cells form prominent clusters in the extravascular compartment of the BM. Some B220+ small lymphocytes, as well as large lymphoid cells, enter BM sinusoids. However, in addition. large numbers of B220+ cells exhibit nuclear chromatin condensation, fragmentation, and other morphologic features characteristic of HE GENESIS OF B lymphocytes in the bone marrow (BM) represents a balance between two opposing processes, cell production and cell loss. After undergoing several cycles of proliferation, many precursor B cells in normal BM are lost at the pre-B-cell stage of development."' In vivo studies have suggested that the cells undergo apoptotic cell death and are cleared by local ma~rophages.4.~ This process of cell deletion appears to provide a way to regulate cell numbers and to eliminate nonfunctional or potentially harmful cells arising as a result of developmental errors.
HE GENESIS OF B lymphocytes in the bone marrow
(BM) represents a balance between two opposing processes, cell production and cell loss. After undergoing several cycles of proliferation, many precursor B cells in normal BM are lost at the pre-B-cell stage of development."' In vivo studies have suggested that the cells undergo apoptotic cell death and are cleared by local ma~rophages. 4 .~ This process of cell deletion appears to provide a way to regulate cell numbers and to eliminate nonfunctional or potentially harmful cells arising as a result of developmental errors.
Transgenic mice in which the c-myc proto-oncogene is driven by the Ig heavy chain enhancer develop malignant tumors of pre-B-or B-lymphocyte phenotype. ' The BM of such Ep-myc transgenic mice shows a prolonged polyclonal expansion of precursor B cells before a frank monoclonal tumor appears in the peripheral tissues.' The pretumorous phase is characterised by increases of twofold to threefold in the number and proliferative activity of certain pro-B cells, before the synthesis of p-chains, and of pre-B cells, expressing p-chains in the cytoplasm. In contrast, the number of IgM-bearing B lymphocytes shows no increase in the spleen and is actually reduced to half normal numbers in the apoptotic cell death. Propidium iodide staining and flow cytometry of BM cells from pretumorous €p-myc transgenic mice, as well as agarose gel electrophoresis of DNA, confirm extensive apoptosis. Many B220+ apoptotic cells are closely associated with the extensive processes of prominent macrophages that contain numerous B220+ apoptotic bodies and complex lysosomal systems. These results suggest that the constitutive expression of c-myc oncogene in BM B-lineage cells, which increases the proliferation of precursor B cells, also leads to increased apoptotic cell death and rapid elimination by resident macrophages. Further mutations may be needed to block these protective mechanisms and permit surviving c-myc-dysregulated cells to leave the BM and to initiate tumorigenesis. 0 1994 by The American Society of Hematology.
BM and peripheral blood.' These findings suggest that a large number of pre-B cells in Ep-myc transgenic mice are being lost through cell death.7 If so, the Ep-myc transgenic mouse provides a model to examine the mechanisms of loss in the B-cell lineage, an important factor in understanding the steps involved in the progression from benign polyclonal expansion of precursor cells in the BM to the dissemination of a neoplastic clone.
The present study identifies B-lineage cells within the BM of pretumorous Ep-myc transgenic mice to examine their proliferation, cell death mechanisms, and interactions with stromal cells in vivo. The B220 glycoprotein expressed on the surface of precursor B cells has been shown by in vivo binding of a radiolabeled monoclonal antibody (MoAb) and detected by electron microscope radioautography: BM cells have also been examined for evidence of DNA degradation both biochemically and through flow cytometry. The results show increased apoptosis and macrophage-mediated deletion of B220' cells, mechanisms that may protect against the dissemination of c-myc-dysregulated cells.
MATERIALS AND METHODS
Mice. Male and female CS7BL/6JSmn (B6) mice and C57BU 6JSmn-Ep-myc (Ep-myc) mice were produced as de~cribed.~.' At 3 weeks of age, mice carrying the transgene were identified by the presence of large proliferating lymphoid cells in the peripheral blood, as shown by flow cytometry."
Pretumorous Ep-myc and control mice were used at 2 to S months of age, the former having been immediately previously confirmed as not yet having detectable endstage tumor cells in the blood.* Anribody and radioiodinarion. MoAb 14.8 binds to an extracellular domain of the B220 glycoprotein, a member of the leukocyte common antigen family (Ly5 or CD45R). Aliquots (150 p g ) of affinity-purified, concentrated MoAb 14.8 (2 mglmL) were coupled to 1.5 mCi Na'251 (specific activity, 1.5 X IO7 pcilpg) using a modified chloramine-T method of iodination described previously.' The final concentration of radiolabeled MoAb 14.8 was approximately 100 p g h L in phosphate-buffered saline (PBS; pH 7.2).
In vivo immunolabeling and tissue petfusion. Six pretumorous Ep-myc mice and 3 age-matched control B6 mice were anesthetized with an intraperitoneal injection of chloral hydrate (1.6% wt/vol in Tissue processing and rudioctutogrcrphy. Femoral shafts of perfusion-fixed mice were removed and placed in glutaraldehyde-acrolein fixative overnight at 4°C before decalcification in EDTA (10% wt/vol at 4°C) for 4 to 7 days. Decalcified tissue was postfixed in potassium ferrocyanide-reduced osmium tetroxide, dehydrated through increasing concentrations of acetone, and infiltrated and embedded in Epon 812 (J.B. EM). Hardened Epon blocks were trimmed to expose a mid-diaphyseal face of BM. Transverse sections of femoral BM were cut at thicknesses of I pm for light microscopy (LM) and 70 to 85 nm for electron microscopy (EM). LM sections werc placed on glass slides. coated with Kodak NTB2 emulsion (Kodak Canada, Toronto, Ontario, Canada), and exposed for I to 6 weeks. EM sections were placed on celloidin-coated glass slides, coated with a monolayer of llford L4 emulsion (Ilford. Essex, UK), and exposed for 10 to 24 weeks. After developing the emulsion, sections were floated off the slides and placed on copper grids. The celloidin was removed and sections were stained in aqueous uranyl acetate and lead citrate. A total of approximately 30 grids, each representing a complete cross-section of BM, were scanned completely and photographed on a Phillips 400 electron microscope (Phillips 400, Eindhoven, The Netherlands).
Preparation of BM DNA and gel electrophoresis. To demonstrate conventional apoptotic oligonucleosomal DNA ladders, DNA was extracted from BM cells as described.",'7 Aliquots of 20 pg were electrophoresed in 1.8% agarose gels in TAE buffer, after which the gels were stained with ethidium bromide and photographed on UV light box. In contrast, to examine earlier phases of DNA degradation during apoptosis," intact cells were embedded at 4 X 107/mL in 0.6% InCert agarose (FMC Corp. Rockland, ME), cut into 20-pL plugs, and digested with protease K ( I mglmL) at 55°C for 48 hours in ELP buffer (0.5 mol/L EDTA. 0.1 % laurlsarcosine). After washing in TEP buffer (10 mmol/L Tris-HCI, pH 7, IO mmol/L EDTA. and 2 m m o l L phenylmethylsulfonyl fluoride), plugs containing high molecular weight DNA were electrophoresed in a Hula-gel pulse field apparatus (Hoeffer Scientific CO, San Francisco, CA). Electrophoresis conditions were 0.5% GTG-gold agarose (FMC), 0 . 5~ TBE buffer, 180 v, 20 hours, I 10" angle. interrupted current, 5 to 1 0 0 second ramp, and 8°C.
Propidium iodide ( P I ) staining and flow cytometn'. Cells were expressed from bone shafts and stained with anti-B220 antibody as previously de~cribed.~ PI was used to assess the viability of stained BM cell suspensions," as well as to measure nuclear DNA degradation, an indication of apoptosis." in radial directions and sometimes spherical in shape (Fig  la) . The B220' cells were considerably more conspicuous than in age-matched nontransgenic control mice (Fig Ib) .
RESULTS

In
The ultrastructure and relationships of B220' cells were demonstrated by EM radioautography. Labeled cells were identified by radioautographic grains closely overlying the cell membrane, whereas background grains were few or absent (Figs 2 through 6). Many B220' cells in Ep-myc mouse BM were large cells having the undifferentiated morphology of early precursor B cells. Nuclear chromatin was dispersed, except for a thin rim of condensed chromatin, whereas plentiful cytoplasm contained several mitochondria, a few profiles of rough endoplasmic reticulum, and, occasionally, some spherical, membrane-bound, electron-dense granules (Fig  2a) . Labeled B220' cells of more differentiated morphology were also present, including typical small lymphocytes of mature B-cell form, characterized by a compact euchromatic nucleus surrounded by a narrow rim of cytoplasm containing few organelles (Fig 2a) . Large B220' cells were commonly seen in mitosis, occasionally in small groups (Fig 2b) , with greater frequency than in control mice (data not shown).
For personal use only. on October 22, 2017. by guest www.bloodjournal.org From Clusters of B220' cells, totalling as many as 15 cells (usually 6 to 8 cells) in the plane of an EM section (Fig  3) , were located in all regions of the BM. Cells of least differentiated morphology were most prominent in the peripheral zone near the surrounding bone and in intermediate areas, whereas many clusters of small lymphocytes were located near the central sinus or tributary sinusoids. The clusters of small lymphocytes were more numerous and larger in E p -m y transgenic mice than in control mice (data not shown). Large undifferentiated B220' cells were often intimately associated with processes of stromal reticular cells in peripheral and intermediate regions of the BM. More central B220+ small lymphocytes were sometimes associated with adventitial reticular cells (data not shown).
B220' cells were also present within the lumen of many venous sinusoids in the BM of Ep-myc transgenic mice. These cells showed an unusually wide range of morphology (Fig 4) . In addition to typical small lymphocytes, as seen within the sinusoids of normal mice (Fig 4a and d) , the sinusoids in Ep-myc transgenic mice often contained larger immature B220' cells having more cytoplasm, mitochondria, and rough endoplasmic reticulum, and a less condensed nuclear chromatin pattern (Fig 4b and c) . The intrasinusoidal cells varied widely in B220 intensity, showing from high to low levels of radioautographic labeling distributed evenly around the plasma membrane (Fig 4) . Occasional segments of venous sinusoids contained localised concentrations of intraluminal B220' small lymphocytes (data not shown). A unique feature of Ep-mvc mouse BM was the presence within most of the sinusoids of aggregates of erythrocytes, 10 to 100 pm in cross-sectional diameter, apparently wrapped in cytoplasmic processes from cells of unknown identity (Fig 4d) .
Apoptotic B-lineage cells in the BM of Ep-myc transgenic mice. The most striking feature of the BM of Ep-myc transgenic mice was the presence of many B220' cells showing distinct morphologic evidence of apoptosis (programmed cell death). Many MoAb 14.8-binding cells showed marked compaction of the nuclear chromatin that was segregated into sharply delineated, intensely electron-dense crescentic masses lying against an intact nuclear envelope (Fig 5a and  b) . The cytoplasm was of moderately increased electron density (Fig h ) , contained intact mitochondria and rough endoplasmic reticulum, and sometimes showed a concentration of organelles in regions of cytoplasmic protrusion (blebbing; Fig 5b) . In some cases, the compacted peripheral chromatin gave the nucleus a convoluted outline (Fig 5c) . The B220' apoptotic cells generally showed light labeling by ?-MoAb 14.8 and the label was often confined to one pole of the cells (Fig 5a, b. and c) . Some membrane-bound apoptotic bodies were considerably smaller than normal B cells, apparently the result of nuclear and cellular fragmentation. Certain nuclear remnants showed peripheral chromatin crescents, whereas others were completely electron dense in crosssection (Fig 5d) . The nuclear and cytoplasmic components of the apoptotic bodies varied considerably in volume (Fig  5d) . Occasionally, apoptotic cells occurred in small groups (2 to 4 cells), sometimes adjacent to well-labeled B220'
For personal use only. on October 22, 2017. by guest www.bloodjournal.org From (Fig 5d) . The total incidence of apoptotic cells per section appeared to be at least I O times higher than normal in BM of E p -m y transgenic mice. Moreover, the extreme degrees of apoptotic morphology commonly observed among B220' cells in the BM of E p -m y transgenic mice were only rarely encountered in the BM of nontransgenic mice (data not shown).
cells of normal morphology
Macrophages in the BM of Ep-myc transgenic mice. Large, pale-staining macrophages were a prominent feature of Ep-mvc transgenic mouse BM viewed by light microscopy (Fig l) . These cells were distributed throughout the BM, most frequently in central areas, and were characterized by many large phagocytic inclusions, sheets of crystalloid bodies, and brown lipofuscin-like granules. The macrophages were much more evident than in nontransgenic control mice (Fig Ib) . EM showed many apoptotic B220' cells intimately associated with the macrophages (Figs 5 and 6) . Some frankly apoptotic B220' cells were either in contact with macrophages or were partially enveloped by cytoplasmic processes that extended from the macrophages between the hemopoietic cells (Fig 5d) . Many small apoptotic bodies and cytoplasmic blebs labeled with the MoAb 14. 8 were also seen to be phagocytosed (Fig 5d) . In some cases, B220' apoptotic cells were completely surrounded by the cytoplasm of large macrophages (Fig 6) . These macrophages had copious electron lucent cytoplasm that also contained unlabeled apoptotic cell fragments, heterogeneous phagolysosomal vesicles, a complex tubular-lysosomal network (Fig  6) . and, in many cases, membrane-bound crystalloids that presented either a linear or rectangular profile according to the plane of section (data not shown).
PI staining andfiow cytometnl of BM cells from Ep-myc mice. Permeability to PI was examined as an indication of cell viability. Flow cytometric analysis of BM cell suspensions showed an increased incidence of live B220' cells that totally excluded PI in BM of E p -m y transgenic mice compared with control mice (Fig 7a and b) . The increase was restricted to precursor B cells expressing low intensities of B220 (Fig 7, region RI) . These cells doubled in incidence. In contrast, mature B cells with high B220 expression were actually reduced in number. These changes in precursor B cells and B cells in E p -m y transgenic mice are consistent For with previous population dynamics data.7 However, in addition, the Ep-myc BM showed an approximate doubling of B220+ cells that stained lightly with PI (Fig 7, region R3) . Such cells, probably in the process of dying, were mainly confined to precursor B cells expressing low levels of B220. In nontransgenic mice, light PI staining was not only less frequent than in the transgenics, but was divided equally between high and low B220+ cells. These findings are consistent with previous data indicating enhanced cell death at the pre-B-cell stage in Ep-myc transgenic mice.7 There was no increase in lightly PI-stained cells among B220-cells in Ep-myc mouse BM (Fig 7) , suggesting that the increased apoptosis was limited to the B-cell lineage. Fully dead cells (Fig 7, region R4) were twice as frequent in Ep-myc BM as in control BM.
The DNA content of nuclei of BM cells from control and Ep-myc transgenic mice was also assessed by PI staining and flow cytometry (Fig 7c and d) . Particles with low (<2 N) content of DNA (region M 1 , Fig 7c and d) , an acknowledged measure of apoptotic activity,I3 were more than three times as frequent in BM of Ep-myc transgenic mice as in control mice. In addition, there was an increased ratio of cells in the S , G*, and M phases of cell cycle (region M4 , Fig 7c and BM cells. Conventionally prepared DNA from BM cells of pretumorous Ep-m-yc mice showed an enhanced oligonucleosoma1 appearance on agarose gel electrophoresis as compared with age-matched control mice (data not shown). Such "DNA laddering" is a classical signature of apoptotic, as opposed to necrotic cell death." Figure 8 presents a pulsefield electrophoretic study of BM cell DNA; the early phases of apoptotic cell death show increased amounts of DNA fragments in the 50 to 500 kb range due to initial endonucleolytic activity acting on higher-order DNA packings in the chromosome.'* BM DNA from Ep-myc mice showed a clearly enhanced amount of such 50 to 500 kb fragments as compared with that from control mice, as indicated by the increased intensity of the DNA smear in the lanes from the four transgenic mice. The c-myc protein has been implicated in the control of normal cell growth and division, possibly functioning as a transcription factor?'.22 As cells differentiate, they rapidly downregulate c-myc mRNA and p r~t e i n . '~"~ Inappropriate c-myc expression can disrupt this growth regulation.23
Some B-lineage cells produced in the BM of Ep-myc transgenic mice successfully enter the blood stream. The demonstration of small B220+ ceIls within the lumen of marrow sinusoids resembles the findings in normal mice, in which these cells have been shown to be sIgM+ B ~e l l s . '~,~~ In prelymphomatous E@-myc transgenic mice, therefore, some mature B lymphocytes are apparently being exported from BM. However, in addition, the presence within BM sinusoids of some large immature B-lineage cells, binding IOW amounts of MoAb 14.8, is a feature of Ep-myc transgenic mice not normally seen in nontransgenic animals. Possibly, B220+ cells expressing large amounts of c-myc protein may not follow an entirely normal differentiation pathway and may acquire cell surface properties allowing the cells to be released from BM before terminal differentiation. Circulating blast-like B-lineage cells are a prominent feature in early postnatal Ep-myc transgenic m i~e .~.~ During the subsequent prelymphomatous phase, the small number of such cells entering the sinusoids within the BM may be difficult to detect in the blood stream, especially if the circulation time taken to reach their peripheral destination is short. The significance of the erythrocyte aggregates and unidentified cytoplasmic processes within BM sinusoids of Eh-myc transgenic mice remains to be determined.
For The enhanced cell loss previously shown to be occurring at the pre-B-to B-cell stage in BM of Ep-myc transgenic mice7 is now demonstrated to be due to a process of apoptosis. The observed changes in nuclear chromatin and cytoplasmic features are the classical morphologic characteristics of programmed cell death,".2' whereas B220 labeling identifies the apoptotic cells as cells of the B lineage. DNA fragmentation, another hallmark of apoptosis,".27 is also demonstrably increased among B-lineage cells in Ep-myc transgenic mice as shown by both flow cytometry and gel electrophoresis. Precursor B-cell loss in normal mice' has also been observed to be associated with apoptosis.4.' Normal murine BM B220' cells are readily susceptible to apoptosis after exposure to glucocorticoids and ionising radiation in vitro.2R The low intensity and polar distribution of B220 expression by apoptotic cells in Ep-myc transgenic mice may indicate that they are relatively immature precursor B cells. Alternatively, the apoptotic process may be associated with an unusually rapid shedding or capping of ligated B220 glycoprotein. Loss of B-lineage cells can occur at various stages of precursor cell differentiation and for various reasons depending on the nature of the Most B-cell loss at the pre-B-to B-cell stage probably reflects the elimination of cells with nonfunctional Ig gene rearrangements"'.'' and of cells with Ig receptors that are autoreactive for local membrane-bound determinant^.'^.'^ However, in addition, the JACOBSEN ET AL present work emphasizes that self-destruction of B-lineage cells may be directed by genes other than Ig. c-myc expression has been linked to the process of apoptosis. Transfection of the c-myc oncogene into growth-arrested fibroblasts can induce both proliferation and a concomitant increase in apoptotic cell death.'"'" Apoptosis associated with dysregulated c-myc expression in T-cell hybridomas can be inhibited by antisense c-myc oligonucleotides?' Apoptotic myc-dysregulated cells can also be rescued, however, by coexpression of the hcl-2 0ncogene,4".~* suggesting that a balance of gene expression regulates cell survival.
Another major insight from the present work is that of the rapid elimination of apoptotic B220' cells from BM of Ep-myc transgenic mice by the activity of local macrophages. A period of IO to 20 minutes was allowed to elapse between the injection of I2'I-MoAb 14.8 and the BM sampling procedure. After this time interval, many B220' cells, which presumably had been labeled by exposure to the antibody while they were located in the BM extravascular space, were already found to be surrounded by the cytoplasm of macrophages, apparently having been ingested by them. The more evident increase of larger (50 to 500 kb) rather than oligonucleosomal (multiples of 200 bps) DNA fragments in Ep-myc versus control BM also supports the rapidity of the cell elimination in situ once the apoptotic process has begun. The vigor of this process, probably mediated by the expression of specific recognition receptorsT4' may explain why apoptotic cells are seen only infrequently in either normal or perturbed BM. Similarly, although cell death also occurs on a large scale in the thymic cortex:' .4R few apoptotic cells can be found at any given time. We have previously observed a comparable intensity of macrophage activity and cell death only in BM of mice treated with anti-IgM antibodies from birth: in which all newly formed B-lineage cells abort and are deleted at the pre-B-to B-cell tran~ition.~~."The resident macrophages of BM, whose complex processes permeate the extravascular space, apparently provide an efficient system to recognize, bind, ingest, and degrade apoptotic B-lineage cells.
Because of the speed with which apoptotic cells are cleared from the BM by resident macrophages, the present techniques can give only a semiquantitative comparison of the true magnitude of apoptosis among B-lineage cells in Epmyc versus control BM. The twofold to threefold increase in frequency of apoptotic B220' cells detected by flow cytometry could suggest that the enhanced cell death simply reflects the general expansion of B220' cells in BM, induced by the Ep-myc transgene." On the other hand, previous population dynamics data' and the striking increase in the number of cells with advanced apoptotic morphology now observed by EM both suggest a disproportionately high degree of apoptosis among B-lineage cells in Ep-myc transgenic mice. Further kinetic studies are required to establish the actual rates at which cells undergo apoptosis and are ingested by macrophages under the influence of the Ep-myc transgene.
The combination of apoptosis and macrophage deletion appears to provide an efficient screening mechanism to eliminate unwanted B-lineage cells that would be either functionless or potentially harmful if allowed to disseminate. The For personal use only. on October 22, 2017. by guest www.bloodjournal.org From
